Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring SF3B1 or U2AF1 Mutations

Abstract
This study has developed a novel NMD reporter system and identified a potential therapeutic approach of targeting the NMD pathway to treat cancer with spliceosome gene mutations.
Funding Information
  • NCI (P01 CA101937)
  • NIH (R01GM098535)
  • Siteman Investment Program Awards (4036, 5124)
  • Washington University (4036,5124)
  • Developmental Research Program (DRP-1901)
  • NCI (P50CA171963)
  • Edward P. Evans Foundation